Log In
BCIQ
Print this Print this
 

AST-005

  Manage Alerts
Collapse Summary General Information
Company Exicure Inc.
DescriptionTopical spherical nucleic acid-based therapeutic targeting tumor necrosis factor (TNF)
Molecular Target Tumor necrosis factor (TNF)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid
Latest Stage of DevelopmentPhase I
Standard IndicationPsoriasis
Indication DetailsTreat chronic plaque psoriasis; Treat psoriasis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$790.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/12/2016

$790.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today